ASHTON KELLEY: Open Payments
NPI 1275048894 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 44 payments from 15 companies in 2025. Trend: 2023 $1,731 · 2024 $2,334 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $230 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| GENZYME CORPORATION | 5 | $109 |
| Genentech USA, Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Lilly USA, LLC | 3 | $50 |
| Grifols USA, LLC | 2 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $42 |
| Optinose US, Inc. | 2 | $42 |
Products named: DUPIXENT, TEZSPIRE, XOLAIR, AIRSUPRA, EBGLYSS, Prolastin-C Liquid, NEFFY, Xhance.
Industry payments across NC — which companies pay providers there.
